CIBC Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$378K Hold
1,999
﹤0.01% 884
2025
Q4
$340K Hold
1,999
﹤0.01% 908
2025
Q3
$263K Hold
1,999
﹤0.01% 996
2025
Q2
$212K Sell
1,999
-12
-0.6% -$1.3K ﹤0.01% 1083
2025
Q1
$250K Buy
2,011
+39
+2% +$5.09K ﹤0.01% 955
2024
Q4
$243K Buy
1,972
+97
+5% +$11.4K ﹤0.01% 996
2024
Q3
$209K Buy
+1,875
New +$205K ﹤0.01% 1091
2024
Q2
Sell
-2,124
Closed -$256K 1176
2024
Q1
$256K Buy
2,124
+4
+0.2% +$490 ﹤0.01% 894
2023
Q4
$261K Sell
2,120
-144
-6% -$18K ﹤0.01% 863
2023
Q3
$293K Buy
2,264
+121
+6% +$16.1K ﹤0.01% 802
2023
Q2
$266K Buy
2,143
+2
+0.1% +$269 ﹤0.01% 843
2023
Q1
$313K Buy
+2,141
New +$317K ﹤0.01% 796
2015
Q3
Sell
-81,798
Closed -$14.4M 957
2015
Q2
$14.4M Sell
81,798
-2,242
-3% -$403K 0.1% 87
2015
Q1
$14.5M Sell
84,040
-2,183
-3% -$375K 0.1% 84
2014
Q4
$14.1M Sell
86,223
-20,136
-19% -$3.34M 0.09% 85
2014
Q3
$17.1M Buy
106,359
+2,789
+3% +$429K 0.1% 83
2014
Q2
$15.2M Buy
103,570
+1,350
+1% +$187K 0.09% 102
2014
Q1
$14.2M Buy
+102,220
New +$15.4M 0.08% 103

Other funds holding JAZZ

CIBC Asset Management's JAZZ Position: Q1 2026 in Review

CIBC Asset Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 1,999 shares worth $378K. The position accounts for ﹤0.01% of the portfolio, ranked #884.

CIBC Asset Management first reported a position in JAZZ in Q1 2014 and has held it in 18 quarters since. The position peaked at $17.1M in Q3 2014. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • CIBC Asset Management held 1,999 shares of Jazz Pharmaceuticals worth $378K as of Q1 2026.
  • CIBC Asset Management left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of CIBC Asset Management's portfolio in Q1 2026, its #884 holding.
  • CIBC Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 18 quarters since.
  • CIBC Asset Management's Jazz Pharmaceuticals position peaked at $17.1M in Q3 2014.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on CIBC Asset Management's 13F filing for Q1 2026, filed 12 May 2026.